206
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Rapid Quantification of Free and Glucuronidated Thccooh in Urine Using Coated Well Plates and LC–MS/MS Analysis

, , &
Pages 485-496 | Received 07 Nov 2016, Accepted 20 Dec 2016, Published online: 08 Feb 2017

References

  • United Nations Office on Drugs and Crime (UNODC) . World Drug Report 2016. United Nations, Vienna, Austria (2016). www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf.
  • Macdonald S , HallW, RomanP, StockwellT, CoghlanM, NesvaagS. Testing for cannabis in the work-place: a review of the evidence. Addiction105 (3), 408–416 (2010).
  • Huestis MA , MazzoniI, RabinO. Cannabis in sport: anti-doping perspective. Sports Med. 41 (11), 949–966 (2011).
  • Pesce A , WestC, RosenthalMet al. Illicit drug use in the pain patient population decreases with continued drug testing. Pain Physician14 (2), 189–193 (2011).
  • Wille SM , Ramirez-Fernandez MdelM, SamynN, De BoeckG. Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges. Bioanalysis2 (4), 791–806 (2010).
  • Lemos NP , IngleEA. Cannabinoids in postmortem toxicology. J. Anal. Toxicol. 35 (7), 394–401 (2011).
  • Moeller KE , LeeKC, KissackJC. Urine drug screening: practical guide for clinicians. Mayo Clin. Proc. 83 (1), 66–76 (2008).
  • Maquille A , GuillarmeD, RudazS, VeutheyJ-L. High-throughput screening of drugs of abuse in urine by supported liquid-liquid-extraction and UHPLC coupled to tandem MS. Chromatographia70 (9), 1373–1380 (2009).
  • Huestis MA . Human cannabinoid pharmacokinetics. Chem. Biodivers. 4 (8), 1770–1804 (2007).
  • Phan HM , YoshizukaK, MurryDJ, PerryPJ. Drug testing in the workplace. Pharmacotherapy32 (7), 649–656 (2012).
  • Gomes RL , MeredithW, SnapeCE, SephtonMA. Analysis of conjugated steroid androgens: deconjugation, derivatisation and associated issues. J. Pharm. Biomed. Anal. 49 (5), 1133–1140 (2009).
  • Schwope DM , ScheidweilerKB, HuestisMA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry. Anal. Bioanal. Chem. 401 (4), 1273–1283 (2011).
  • Clatworthy AJ , OonMC, SmithRN, WhitehouseMJ. Gas chromatographic–mass spectrometric confirmation of radioimmunoassay results for cannabinoids in blood and urine. Forensic Sci. Int. 46 (3), 219–230 (1990).
  • Kelly P , JonesRT. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J. Anal. Toxicol. 16 (4), 228–235 (1992).
  • Kemp PM , AbukhalafIK, MannoJE, MannoBR, AlfordDD, AbusadaGA. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J. Anal. Toxicol. 19 (5), 285–291 (1995).
  • Crockett DK , NelsonG, DimsonP, UrryFM. Solid-phase extraction of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid from urine drug-testing specimens with the cerex polycrom-THC column. J. Anal. Toxicol. 24 (4), 245–249 (2000).
  • Stout PR , HornCK, KletteKL. Solid-phase extraction and GC-MS analysis of THC-COOH method optimized for a high-throughput forensic drug-testing laboratory. J. Anal. Toxicol. 25 (7), 550–554 (2001).
  • Boldis O , KocsisG, GachalyiA, FureszJ. Gas chromatography–mass spectrometry–single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine. J. Chromatogr. Sci. 41 (4), 190–194 (2003).
  • Abraham TT , LoweRH, PirnaySO, DarwinWD, HuestisMA. Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis. J. Anal. Toxicol. 31 (8), 477–485 (2007).
  • Kemp PM , AbukhalafIK, MannoJEet al. Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine. J. Anal. Toxicol. 19 (5), 292–298 (1995).
  • Kaushik R , LevineB, LacourseWR. A brief review: HPLC methods to directly detect drug glucuronides in biological matrices (Part I). Anal. Chim. Acta556 (2), 255–266 (2006).
  • Schwilke EW , SchwopeDM, KarschnerELet al. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin. Chem. 55 (12), 2180–2189 (2009).
  • Skopp G , PötschL. Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin. Chem. 48 (2), 301–306 (2002).
  • Gronewold A , SkoppG. A preliminary investigation on the distribution of cannabinoids in man. Forensic Sci. Int. 210 (1–3), e7–e11 (2011).
  • Felli M , MartelloS, ChiarottiM. LC–MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: application to workplace confirmation tests. Forensic Sci. Int. 204 (1–3), 67–73 (2011).
  • De Jager AD , BaileyNL. Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879 (25), 2642–2652 (2011).
  • Scheidweiler KB , DesrosiersNA, HuestisMA. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clin. Chem. Acta413 (23–24), 1839–1847 (2012).
  • Kim JY , KwonW, KimHS, SuhS, InMK. Estimation of measurement uncertainty for the quantification of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and its glucuronide in urine using liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 38 (3), 164–170 (2014).
  • Andersson M , ScheidweilerKB, SempioC, BarnesAJ, HuestisMA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Anal. Bioanal. Chem. 408 (23), 6461–6471 (2016).
  • Beck O , EricssonM. Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC–HRMS. Bioanalysis6 (17), 2229–2244 (2014).
  • Chiu ML , LawiW, SnyderST, WongPK, LiaoJC, GauV. Matrix effects – a challenge toward automation of molecular analysis. J. Assoc. Lab. Automat. 15 (3), 233–242 (2010).
  • Knaack J . Solid phase extraction for the HPLC–MS/MS clinical analysis: finding a needle in a haystack. Pharmaceut. Anal. Acta3 (10), e141 (2012).
  • Matuszewski BK , ConstanzerML, Chavez-EngCM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 70 (5), 882–889 (1998).
  • Bylda C , ThieleR, KoboldU, VolmerDA. Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC–MS/MS. Analyst139 (10), 2265–2276 (2014).
  • Hädener M , WeinmannW, SchürchS, KönigS. Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency. Anal. Bioanal. Chem. 408 (7), 1953–1962 (2016).
  • Guidance for Industry Bioanalytical Method Validation . US Department of Health and Humans Services. US FDA, Rockville, MD, USA (2001). www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf.
  • Guideline on bioanalytical method validation . EMA, London, UK (2011). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
  • Almeida AM , Castel-BrancoMM, FalcaoAC. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 774 (2), 215–222 (2002).
  • Matuszewski BK , ConstanzerML, Chavez-EngCM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal. Chem. 75 (13), 3019–3030 (2003).
  • Wohleb R , GeyerR, EckardS. White Paper: Technical Background to the Tecan AC Extraction Plate™. Tecan Trading AG, Männedorf, Switzerland (2013).
  • Tecan Trading AG . Technical Note: Efficiency of Extraction: The Influence of pH. Männedorf, Switzerland (2013).
  • Zell M , HusserC, HopfgartnerG. Column-switching high-performance liquid chromatography combined with ionspray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44-3888 and its pro-drug and precursor metabolite in plasma. J. Mass Spectrom. 32 (1), 23–32 (1997).
  • Timm U , ZumbrunnenR, ErdinR, SingerM, SteinerB. Oral platelet aggregation inhibitor Ro 48-3657: determination of the active metabolite and its prodrug in plasma and urine by high-performance liquid chromatography using automated column switching. J. Chromatogr. B Biomed. Sci. Appl. 691 (2), 397–407 (1997).
  • Koal T , DetersM, CasettaB, KaeverV. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 805 (2), 215–222 (2004).
  • Brunetto Mdel R , ContrerasY, DelgadoY, GallignaniM, EstelaJM, MartinVC. Development and validation of a rapid column-switching high-performance liquid chromatographic method for the determination of Lamotrigine in human serum. J. Chromatogr. Sci. 47 (6), 478–484 (2009).
  • Zanchetti G , FlorisI, PiccinottiA, TameniS, PolettiniA. Rapid and robust confirmation and quantification of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in urine by column switching LC–MS-MS analysis. J. Mass Spectrom. 47 (1), 124–130 (2012).
  • Satinsky D , HavlikovaL, SolichP. HPLC column-switching technique for sample preparation and fluorescence determination of propranolol in urine using fused-core columns in both dimensions. Anal. Bioanal. Chem. 405 (20), 6583–6587 (2013).
  • Wickremsinhe ER , LeeLB, SchmalzCA, TorchiaJ, RuterboriesKJ. High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 932, 117–122 (2013).
  • Alves MN , ZanchettiG, PiccinottiA, TameniS, De MartinisBS, PolettiniA. Determination of cocaine and metabolites in hair by column-switching LC–MS-MS analysis. Anal. Bioanal. Chem. 405 (19), 6299–6306 (2013).
  • González-Ruiz V , OlivesAI, MartínMA. Core-shell particles lead the way to renewing high-performance liquid chromatography. Trends Anal. Chem. 64, 17–28 (2015).
  • Skopp G , PotschL. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples. J. Anal. Toxicol. 28 (1), 35–40 (2004).
  • Desrosiers NA , LeeD, ScheidweilerKBet al. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Anal. Bioanal. Chem. 406 (3), 785–792 (2014).
  • Desrosiers NA , LeeD, Concheiro-GuisanM, ScheidweilerKB, GorelickDA, HuestisMA. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?Clin. Chem. 60 (2), 361–372 (2014).
  • Shipkova M , ArmstrongVW, OellerichM, WielandE. Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther. Drug. Monit. 25 (1), 1–16 (2003).
  • Lenz EM , GreatbanksD, WilsonIDet al. Direct characterization of drug glucuronide isomers in human urine by HPLC-NMR spectroscopy: application to the positional isomers of 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid glucuronide. Anal. Chem. 68 (17), 2832–2837 (1996).
  • Hasegawa J , SmithPC, BenetLZ. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metab. Dispos. 10 (5), 469–473 (1982).
  • Bradow G , KanLS, FenselauC. Studies of intramolecular rearrangements of acyl-linked glucuronides using salicylic acid, flufenamic acid, and (S)- and (R)-benoxaprofen and confirmation of isomerization in acyl-linked delta 9–11-carboxytetrahydrocannabinol glucuronide. Chem. Res. Toxicol. 2 (5), 316–324 (1989).
  • Peters FT . Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin. Biochem. 44 (1), 54–65 (2011).
  • Xu RN , FanL, RieserMJ, El-ShourbagyTA. Recent advances in high-throughput quantitative bioanalysis by LC–MS/MS. J. Pharm. Biomed. Anal. 44 (2), 342–355 (2007).
  • Vogeser M , KirchhoffF. Progress in automation of LC–MS in laboratory medicine. Clin. Biochem. 44 (1), 4–13 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.